Dr. Lisa Mielniczuk

Dr. Lisa Mielniczuk completed her medical degree at McMaster University and subsequently went on to complete a residency in Internal Medicine from Queen's University and a Cardiology Fellowship at the University of Ottawa Heart Institute. She also completed a fellowship in advanced heart failure/cardiac transplantation at the Brigham and Women's Hospital in Boston - where she also concurrently completed a Master's Degree in Clinical Science and Epidemiology at the Harvard School of Public Health. Prior to joining the Mayo Clinic, Dr. Mielniczuk was a Professor of Medicine at the University of Ottawa and the Director of the Advanced Heart Diseases Program at the Ottawa Heart Institute with a cross-appointed to the Department of Cellular and Molecular Medicine. She was also Vice-Chair for Quality and Clinical Care for the Department of Medicine from 2019-2024. She was the co-Founder and Director of the Ottawa Pulmonary Hypertension Program, and has lead a number of innovative clinical programs including a Rapid Intervention Clinic for HF patients, and a Regional HF program for the Ottawa/Champlain region. Dr. Mielniczuk is an active leader for the HF and Pulmonary Hypertension community and is the current outgoing-Chair for the Pulmonary Hypertension Association of Canada.

Dr. Mielniczuk is a translational scientist with more than 100 peer reviewed papers, and has built a multi-disciplinary right heart failure research program at the University of Ottawa. She has recently joined the faculty at the Mayo Clinic and will be continuing her research and clinical work in heart failure and pulmonary hypertension there.